The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?


Journal

Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422

Informations de publication

Date de publication:
08 2020
Historique:
received: 20 04 2020
revised: 04 05 2020
accepted: 06 05 2020
pubmed: 21 5 2020
medline: 21 7 2020
entrez: 21 5 2020
Statut: ppublish

Résumé

The anti-malarial drugs chloroquine (CQ) and primarily the less toxic hydroxychloroquine (HCQ) are currently used to treat autoimmune diseases for their immunomodulatory and anti-thrombotic properties. They have also been proposed for the treatment of several viral infections, due to their anti-viral effects in cell cultures and animal models, and, currently, for the treatment of coronavirus disease 2019 (COVID-19), the pandemic severe acute respiratory syndrome caused by coronavirus 2 (Sars-Cov-2) infection that is spreading all over the world. Although in some recent studies a clinical improvement in COVID-19 patients has been observed, the clinical efficacy of CQ and HCQ in COVID-19 has yet to be proven with randomized controlled studies, many of which are currently ongoing, also considering pharmacokinetics, optimal dosing regimen, therapeutic level and duration of treatment and taking into account patients with different severity degrees of disease. Here we review what is currently known on the mechanisms of action of CQ and HCQ as anti-viral, anti-inflammatory and anti-thrombotic drugs and discuss the up-to-date experimental evidence on the potential mechanisms of action of CQ/HCQ in Sars-Cov2 infection and the current clinical knowledge on their efficacy in the treatment of COVID-19 patients. Given the role of iron in several human viral infections, we also propose a different insight into a number of CQ and HCQ pharmacological effects, suggesting a potential involvement of iron homeostasis in Sars-Cov-2 infection and COVID-19 clinical course.

Identifiants

pubmed: 32430286
pii: S1043-6618(20)31212-3
doi: 10.1016/j.phrs.2020.104904
pmc: PMC7217799
pii:
doi:

Substances chimiques

Antiviral Agents 0
Hydroxychloroquine 4QWG6N8QKH
Chloroquine 886U3H6UFF
Iron E1UOL152H7

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104904

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: E.Q.R. received travel grants from Bristol-Myers Squibb, Gilead Sciences, ViiV Healthcare, Janssen-Cilag, Merck Sharp & Dohme and consultancy fees from Janssen-Cilag, ViiV Healthcare and Merck Sharp & Dohme. The remaining authors declare that they have no conflicts of interest.

Références

Mol Neurobiol. 2016 Oct;53(8):5542-74
pubmed: 26468157
Mol Biol Rep. 2013 Dec;40(12):6757-64
pubmed: 24065548
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
J Med Virol. 2020 Jul;92(7):915-918
pubmed: 32270515
Vitam Horm. 2019;110:143-156
pubmed: 30798809
Biomed Pharmacother. 2019 Jan;109:2043-2053
pubmed: 30551460
J Clin Immunol. 1993 Mar;13(2):81-92
pubmed: 8320312
Pharmacol Ther. 2017 Dec;180:90-98
pubmed: 28642115
Sci Rep. 2018 May 8;8(1):7296
pubmed: 29740038
J Biol Chem. 1992 Sep 5;267(25):17907-12
pubmed: 1387643
PLoS One. 2012;7(8):e44252
pubmed: 22952941
Int J Antimicrob Agents. 2020 May;55(5):105954
pubmed: 32234467
J Trace Elem Med Biol. 2018 Jul;48:118-133
pubmed: 29773170
Nat Rev Microbiol. 2007 Aug;5(8):577-82
pubmed: 17632569
Antimicrob Agents Chemother. 2002 Mar;46(3):787-96
pubmed: 11850263
Autoimmun Rev. 2012 Oct;11(12):883-9
pubmed: 22449938
Sci Rep. 2017 Oct 23;7(1):13738
pubmed: 29062065
J Virol. 2007 Aug;81(16):8722-9
pubmed: 17522231
Lupus. 2010 Apr;19(4):460-9
pubmed: 20353989
Shock. 2020 Sep;54(3):402-412
pubmed: 31743298
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Am Surg. 1975 Dec;41(12):761-6
pubmed: 1203006
J Thromb Haemost. 2020 May;18(5):1020-1022
pubmed: 32239799
Crit Care. 2014 Aug 06;18(4):470
pubmed: 25096529
Clin Infect Dis. 2020 Jul 28;71(15):732-739
pubmed: 32150618
BMC Cancer. 2018 Jun 22;18(1):678
pubmed: 29929491
Circ Res. 2017 Feb 17;120(4):736-743
pubmed: 28209798
Antiviral Res. 2020 May;177:104762
pubmed: 32147496
Clin Infect Dis. 2020 Nov 19;71(16):2227-2229
pubmed: 32255489
J Biol Chem. 2008 Aug 8;283(32):21899-908
pubmed: 18559340
Int J Antimicrob Agents. 2020 May;55(5):105938
pubmed: 32171740
Int J Antimicrob Agents. 2020 May;55(5):105960
pubmed: 32251731
Int J Hematol. 2018 Jan;107(1):7-15
pubmed: 29147843
Cytokine. 2018 Apr;104:8-13
pubmed: 29414327
Nature. 2014 May 1;509(7498):105-9
pubmed: 24695223
Rheumatology (Oxford). 2005 Oct;44(10):1303-7
pubmed: 16030085
J Clin Virol. 2001 Feb;20(3):137-40
pubmed: 11166662
PLoS One. 2013 Dec 09;8(12):e82952
pubmed: 24349404
Virus Res. 2008 Apr;133(1):101-12
pubmed: 17451827
Eur J Biochem. 1982 Apr 1;123(2):235-40
pubmed: 7075588
Am J Med. 1994 Mar;96(3):254-9
pubmed: 8154514
J Immunol Res. 2014;2014:613136
pubmed: 25136646
Virol J. 2019 May 27;16(1):69
pubmed: 31133031
Travel Med Infect Dis. 2020 Mar - Apr;34:101663
pubmed: 32289548
J Inorg Biochem. 2003 Feb 1;94(1-2):36-42
pubmed: 12620671
Biochem Biophys Res Commun. 2014 Aug 22;451(2):208-14
pubmed: 25073113
Blood. 2000 Jun 1;95(11):3460-6
pubmed: 10828029
Immunol Rev. 2009 Jan;227(1):32-43
pubmed: 19120473
FEBS Lett. 2006 Aug 7;580(18):4533-8
pubmed: 16870179
Clin Orthop Relat Res. 1981 Mar-Apr;(155):21-4
pubmed: 7014058
Metallomics. 2017 Oct 18;9(10):1367-1375
pubmed: 28671201
Clin Orthop Relat Res. 1977;(127):123-32
pubmed: 912966
Thromb Res. 1994 Jun 1;74(5):495-504
pubmed: 8085250
Antiviral Res. 2008 Feb;77(2):150-2
pubmed: 18055026
Cell Discov. 2020 Mar 18;6:16
pubmed: 32194981
Immunol Res. 2017 Feb;65(1):17-24
pubmed: 27406736
J Biol Regul Homeost Agents. 2020 Mar 31;34(2):333-338
pubmed: 32228825
J Autoimmun. 2020 May;109:102442
pubmed: 32253068
Pharmatherapeutica. 1981;3(1):36-9
pubmed: 7323107
Immunology. 1993 Sep;80(1):127-33
pubmed: 8244453
Am J Med. 1990 Sep;89(3):322-6
pubmed: 2393036
Haematologica. 2020 Jan 31;105(2):260-272
pubmed: 31949017
Clin Rev Allergy Immunol. 2012 Apr;42(2):145-53
pubmed: 21221847
PLoS One. 2018 Nov 6;13(11):e0206814
pubmed: 30399161
J Infect. 2020 May;80(5):e14-e17
pubmed: 32171867
Blood. 2008 Sep 1;112(5):1687-95
pubmed: 18577708
Autophagy. 2016;12(1):1-222
pubmed: 26799652
Ann Rheum Dis. 2017 May;76(5):891-897
pubmed: 27903507
Br Med J. 1974 Jul 13;3(5923):94-5
pubmed: 4853767
Blood. 2010 Mar 18;115(11):2292-9
pubmed: 19965621
J Immunol. 1997 May 15;158(10):4901-7
pubmed: 9144507
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
Int Rev Cell Mol Biol. 2019;342:73-93
pubmed: 30635094
Int Immunopharmacol. 2004 Feb;4(2):223-34
pubmed: 14996414
Pharmatherapeutica. 1984;4(1):48-52
pubmed: 6504946
Curr Rheumatol Rep. 2011 Feb;13(1):77-80
pubmed: 20978875
Curr Top Membr. 2012;70:169-214
pubmed: 23177986
Arch Dermatol. 2003 Mar;139(3):309-13
pubmed: 12622622
J Mol Cell Biol. 2020 May 18;12(4):322-325
pubmed: 32236562
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Nat Rev Immunol. 2005 Dec;5(12):917-27
pubmed: 16322745
Med Mal Infect. 2020 Jun;50(4):384
pubmed: 32240719
Br J Exp Pathol. 1979 Apr;60(2):161-6
pubmed: 221001
Cell Res. 2008 Feb;18(2):290-301
pubmed: 18227861
Antiviral Res. 2016 Sep;133:223-33
pubmed: 27521848
Am J Physiol Lung Cell Mol Physiol. 2006 Sep;291(3):L417-25
pubmed: 16648237
Nat Rev Microbiol. 2008 Jul;6(7):541-52
pubmed: 18552864
Nat Rev Immunol. 2020 May;20(5):269-270
pubmed: 32273594
Virol J. 2005 Aug 22;2:69
pubmed: 16115318
Pharmaceuticals (Basel). 2018 Oct 01;11(4):
pubmed: 30275421
Nat Immunol. 2015 May;16(5):448-57
pubmed: 25898198
J Thromb Thrombolysis. 2020 Apr 3;:
pubmed: 32246317
Thromb Haemost. 2002 Mar;87(3):518-22
pubmed: 11916085
Blood Coagul Fibrinolysis. 2015 Jun;26(4):368-72
pubmed: 25688463
Antiviral Res. 2020 Apr;176:104742
pubmed: 32057769
Virusdisease. 2020 Mar;31(1):13-21
pubmed: 32206694
Am J Med. 1988 Oct 14;85(4A):57-61
pubmed: 3052057
Pharmaceuticals (Basel). 2019 Aug 22;12(3):
pubmed: 31443397
Rheumatology (Oxford). 2006 Jun;45(6):703-10
pubmed: 16418198
Microbiol Immunol. 2014 Jun;58(6):318-26
pubmed: 24773578
Diagn Interv Imaging. 2020 May;101(5):323-324
pubmed: 32278585
J Rheumatol. 1997 Jan;24(1):55-60
pubmed: 9002011
Mediators Inflamm. 2019 Nov 13;2019:4038619
pubmed: 31814801
Science. 2012 Nov 9;338(6108):768-72
pubmed: 23139325
Clin Drug Investig. 2018 Aug;38(8):653-671
pubmed: 29737455
Autoimmun Rev. 2020 Jun;19(6):102537
pubmed: 32251717
IUBMB Life. 2017 Jun;69(6):442-450
pubmed: 28474474
Nat Rev Immunol. 2015 Apr;15(4):203-16
pubmed: 25720354
Arthritis Rheumatol. 2017 Mar;69(3):655-667
pubmed: 27696751
Clin Appl Thromb Hemost. 2004 Oct;10(4):387-91
pubmed: 15497026
Cytokine. 2014 Sep;69(1):136-45
pubmed: 24746243
Blood. 1997 Sep 1;90(5):1850-7
pubmed: 9292517
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
J Rheumatol. 1993 May;20(5):803-8
pubmed: 8336306
J Virol. 2018 Jan 30;92(4):
pubmed: 29167338
Arthritis Rheum. 2009 Jan 15;61(1):29-36
pubmed: 19116963
J Rheumatol. 2001 Apr;28(4):780-5
pubmed: 11327250
Circulation. 2020 Jun 2;141(22):1739-1741
pubmed: 32271624
J Clin Immunol. 2003 Nov;23(6):477-84
pubmed: 15031635
Curr Rheumatol Rep. 2016 Apr;18(4):22
pubmed: 26995745
Am J Hematol. 2020 Jul;95(7):876-878
pubmed: 32282956
J Rheumatol. 2013 Jan;40(1):30-3
pubmed: 22859353
Lupus. 2006;15(9):577-83
pubmed: 17080912
Med Trop (Mars). 1990 Jan-Mar;50(1):143-6
pubmed: 2366648
Thromb Res. 2002 Feb 15;105(4):339-45
pubmed: 12031829
Int J Antimicrob Agents. 2020 May;55(5):105955
pubmed: 32234468
Ann Hematol. 2014 Apr;93(4):571-6
pubmed: 24141332
Autoimmun Rev. 2020 Apr;19(4):102491
pubmed: 32084592
Nat Biotechnol. 2020 Apr;38(4):379-381
pubmed: 32205870
PLoS One. 2019 Mar 14;14(3):e0212614
pubmed: 30870459
Cell Calcium. 2018 Jan;69:112-121
pubmed: 28689729
Haematologica. 2020 Feb 20;:
pubmed: 32079699
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Lancet Infect Dis. 2003 Nov;3(11):722-7
pubmed: 14592603
Ann Rheum Dis. 2009 Feb;68(2):238-41
pubmed: 18782792
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466
Int J Mol Sci. 2019 Feb 05;20(3):
pubmed: 30764493
Physiol Genomics. 2020 May 1;52(5):217-221
pubmed: 32275178
J Rheumatol. 2018 Jun;45(6):818-826
pubmed: 29545450
Autoimmun Rev. 2015 Apr;14(4):358-62
pubmed: 25534016
Cells. 2019 Dec 20;9(1):
pubmed: 31861948
Thromb Res. 1982 Feb 1;25(3):219-27
pubmed: 6175045
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Biochem Pharmacol. 1999 Apr 15;57(8):907-11
pubmed: 10086324
Clin Orthop Relat Res. 1979 Oct;(144):174-7
pubmed: 535221

Auteurs

Eugenia Quiros Roldan (E)

University Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy.

Giorgio Biasiotto (G)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy; Clinical Chemistry Laboratory, Cytogenetics and Molecular Genetics Section, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy.

Paola Magro (P)

University Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy.

Isabella Zanella (I)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy; Clinical Chemistry Laboratory, Cytogenetics and Molecular Genetics Section, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy. Electronic address: isabella.zanella@unibs.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH